Vasospastic Angina: An Immune-related Adverse Event

A 54-year-old Japanese woman was admitted to our ward because of recurrent chest pain at rest for 2 months. She had been treated with nivolumab, an immune checkpoint inhibitor for inoperable advanced hypopharyngeal cancer for 21 months. She had no chest pain after cessation of nivolumab treatment. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumamoto, Taku, Kawano, Hiroaki, Kurobe, Masaya, Akashi, Ryohei, Yonekura, Tsuyoshi, Ikeda, Satoshi, Maemura, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334223/
https://www.ncbi.nlm.nih.gov/pubmed/34866103
http://dx.doi.org/10.2169/internalmedicine.8540-21
_version_ 1784759055161491456
author Kumamoto, Taku
Kawano, Hiroaki
Kurobe, Masaya
Akashi, Ryohei
Yonekura, Tsuyoshi
Ikeda, Satoshi
Maemura, Koji
author_facet Kumamoto, Taku
Kawano, Hiroaki
Kurobe, Masaya
Akashi, Ryohei
Yonekura, Tsuyoshi
Ikeda, Satoshi
Maemura, Koji
author_sort Kumamoto, Taku
collection PubMed
description A 54-year-old Japanese woman was admitted to our ward because of recurrent chest pain at rest for 2 months. She had been treated with nivolumab, an immune checkpoint inhibitor for inoperable advanced hypopharyngeal cancer for 21 months. She had no chest pain after cessation of nivolumab treatment. Cardiac catheterization confirmed the presence of vasospastic angina. Benidipine 8 mg was started, and she had no chest pain even after resuming therapy with nivolumab. Vasospastic angina is an adverse effect of nivolumab.
format Online
Article
Text
id pubmed-9334223
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-93342232022-08-15 Vasospastic Angina: An Immune-related Adverse Event Kumamoto, Taku Kawano, Hiroaki Kurobe, Masaya Akashi, Ryohei Yonekura, Tsuyoshi Ikeda, Satoshi Maemura, Koji Intern Med Case Report A 54-year-old Japanese woman was admitted to our ward because of recurrent chest pain at rest for 2 months. She had been treated with nivolumab, an immune checkpoint inhibitor for inoperable advanced hypopharyngeal cancer for 21 months. She had no chest pain after cessation of nivolumab treatment. Cardiac catheterization confirmed the presence of vasospastic angina. Benidipine 8 mg was started, and she had no chest pain even after resuming therapy with nivolumab. Vasospastic angina is an adverse effect of nivolumab. The Japanese Society of Internal Medicine 2021-12-04 2022-07-01 /pmc/articles/PMC9334223/ /pubmed/34866103 http://dx.doi.org/10.2169/internalmedicine.8540-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kumamoto, Taku
Kawano, Hiroaki
Kurobe, Masaya
Akashi, Ryohei
Yonekura, Tsuyoshi
Ikeda, Satoshi
Maemura, Koji
Vasospastic Angina: An Immune-related Adverse Event
title Vasospastic Angina: An Immune-related Adverse Event
title_full Vasospastic Angina: An Immune-related Adverse Event
title_fullStr Vasospastic Angina: An Immune-related Adverse Event
title_full_unstemmed Vasospastic Angina: An Immune-related Adverse Event
title_short Vasospastic Angina: An Immune-related Adverse Event
title_sort vasospastic angina: an immune-related adverse event
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334223/
https://www.ncbi.nlm.nih.gov/pubmed/34866103
http://dx.doi.org/10.2169/internalmedicine.8540-21
work_keys_str_mv AT kumamototaku vasospasticanginaanimmunerelatedadverseevent
AT kawanohiroaki vasospasticanginaanimmunerelatedadverseevent
AT kurobemasaya vasospasticanginaanimmunerelatedadverseevent
AT akashiryohei vasospasticanginaanimmunerelatedadverseevent
AT yonekuratsuyoshi vasospasticanginaanimmunerelatedadverseevent
AT ikedasatoshi vasospasticanginaanimmunerelatedadverseevent
AT maemurakoji vasospasticanginaanimmunerelatedadverseevent

Ejemplares similares